These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10673479)

  • 1. The future for tiotropium.
    Calverley PM
    Chest; 2000 Feb; 117(2 Suppl):67S-9S. PubMed ID: 10673479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
    Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
    Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide.
    Barnes PJ
    Expert Opin Investig Drugs; 2001 Apr; 10(4):733-40. PubMed ID: 11281822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.
    Saberi F; O'Donnell DE
    Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium bromide.
    Gross NJ
    Chest; 2004 Dec; 126(6):1946-53. PubMed ID: 15596697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].
    Ohmura T; Nishikawa H
    Nihon Yakurigaku Zasshi; 2005 May; 125(5):307-13. PubMed ID: 15997169
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety, tolerability and risk benefit analysis of tiotropium in COPD.
    Oba Y; Zaza T; Thameem DM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):575-84. PubMed ID: 19281075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiotropium bromide.
    Lipson DA
    Int J Chron Obstruct Pulmon Dis; 2006; 1(2):107-14. PubMed ID: 18046887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.
    Abrahams R; Moroni-Zentgraf P; Ramsdell J; Schmidt H; Joseph E; Karpel J
    Respir Med; 2013 Jun; 107(6):854-62. PubMed ID: 23490224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL
    An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
    Tang Y; Massey D; Zhong NS
    Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anticholinergics in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Med; 2004 Dec; 117 Suppl 12A():24S-32S. PubMed ID: 15693640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention in chronic obstructive pulmonary disease. POET-COPD (prevention of exacerbations with tiotropium in COPD)].
    Gillissen A; Nitschmann S
    Internist (Berl); 2011 Dec; 52(12):1492-4. PubMed ID: 22033914
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP
    Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.